NASDAQ · FTXH

First Trust Nasdaq Pharmaceuticals ETF (FTXH)

$41.86+0.45%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$41.86▲ 50.42% in range
Sep 29, 2025Low $27.83 · High $42.76Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

First Trust Nasdaq Pharmaceuticals ETF closed at $41.86 on Sep 28, up 0.45%, 2.1% below its 52-week closing high. Volume of 76.5K shares was 0.28× its 20-day average (below normal).

Split-adjusted performance: -0.3% over one month, +26.7% over six months, +53.3% over one year.

Short interest was 19.0K shares at the Sep 15 settlement, down 85.8% from the prior report (1.0 days to cover).

Market cap$1.08B25.8M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield0.11%$0.0113 last paid
52-week range27.30 – 42.76−2.1% from high
Volume76.5K0.28× 20-day avg
Volatility · 60d18.5%Annualised
Short % of float—1.0 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W +1.2%1M −0.3%3M +8.8%6M +26.7%YTD +27.1%1Y +53.3%3Y +60.7%5Y +64.3%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short19.0K−85.8% vs prior
Days to cover1.0Settled Sep 15
% of float—
Short vol. 10d47.4%of daily volume

News about First Trust Nasdaq Pharmaceuticals ETF

All news →

No recent articles focused on First Trust Nasdaq Pharmaceuticals ETF.

Quick answers

What is FTXH's market cap?
$1.08B, based on the Sep 28 close of $41.86.
Does First Trust Nasdaq Pharmaceuticals ETF pay a dividend?
Yes. The latest regular dividend was $0.0113 per share (ex-date Sep 24), an annualised yield of 0.11%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology